Recent changes in the healthcare industry can both contribute to and exacerbate clinician burnout, but can also improve the situation, said Kathleen Blake, MD, MPH, vice president for Performance Improvement at the American Medical Association.
Recent changes in the healthcare industry can both contribute to and exacerbate clinician burnout, but can also improve the situation, said Kathleen Blake, MD, MPH, vice president for Performance Improvement at the American Medical Association.
Transcript
How might recent changes in the health industry—such as value-based payment models and new technologies—exacerbate burnout?
They can exacerbate it, they can also improve it. And I think that that’s true for a lot of the transformational trends going on in healthcare today. The exacerbation, I think, we can point very clearly to the introduction of electronic health records (EHRs) systems that were designed to meet regulatory requirements, but really did not focus as much as they should have on usability, on the EHR function being imbedded into the workflow of clinicians. The second way is that, again, through regulation, there have been a lot of restrictions on how much care can be provided by other members of the care team. Members other than the physician. We’re starting to see some improvements in those areas.
And if you think about alternative payment models, alternative payment models require creativity, adaptability, data, and a commitment. When you already have limited bandwidth, in terms of time, energy, enthusiasm, it’s hard to proceed with an alternative payment model. So, what we would envision is if we can tackle some of the causes of burnout, we will see some of that natural creativity reemerge.
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More